These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25847472)

  • 1. Development and validation of a clinical scale for rating the severity of blepharospasm.
    Defazio G; Hallett M; Jinnah HA; Stebbins GT; Gigante AF; Ferrazzano G; Conte A; Fabbrini G; Berardelli A
    Mov Disord; 2015 Apr; 30(4):525-30. PubMed ID: 25847472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm.
    Ferrazzano G; Muroni A; Conte A; Ercoli T; Tamburini G; Fabbrini G; Berardelli A; Defazio G
    Mov Disord Clin Pract; 2020 Nov; 7(8):950-954. PubMed ID: 33163566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement Properties of Clinical Scales Rating the Severity of Blepharospasm: A Multicenter Observational Study.
    Defazio G; Hallett M; Berardelli A; Perlmutter JS; Berman BD; Jankovic J; Bäumer T; Comella C; Ercoli T; Ferrazzano G; Fox SH; Kim HJ; Moukheiber ES; Pirio Richardson S; Weissbach A; Gigante AF; Jinnah HA
    Mov Disord Clin Pract; 2022 Oct; 9(7):949-955. PubMed ID: 36247913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease progression in blepharospasm: a 5-year longitudinal study.
    Ferrazzano G; Conte A; Gigante A; Defazio G; Berardelli A; Fabbrini G
    Eur J Neurol; 2019 Feb; 26(2):268-273. PubMed ID: 30308706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.
    Müller J; Wissel J; Kemmler G; Voller B; Bodner T; Schneider A; Wenning GK; Poewe W
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):749-53. PubMed ID: 15090572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between various clinical outcome assessments in patients with blepharospasm.
    Jankovic J; Kenney C; Grafe S; Goertelmeyer R; Comes G
    Mov Disord; 2009 Feb; 24(3):407-13. PubMed ID: 19053054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neural network-based software to recognise blepharospasm symptoms and to measure eye closure time.
    Trotta GF; Pellicciari R; Boccaccio A; Brunetti A; Cascarano GD; Manghisi VM; Fiorentino M; Uva AE; Defazio G; Bevilacqua V
    Comput Biol Med; 2019 Sep; 112():103376. PubMed ID: 31386970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.
    Del Sorbo F; Albanese A
    Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal assessment of blepharospasm severity in patients with long disease duration.
    Gentile M; Caccamo M; Vitucci B; Pellicciari R; Velucci V; Muroni A; Defazio G
    Parkinsonism Relat Disord; 2024 Jun; 123():106954. PubMed ID: 38703438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia: a multicenter study.
    Defazio G; Lepore V; Abbruzzese G; Barontini E; Berardelli A; Caraceni T; Carella F; Girlanda P; Manfredi M; Messina C
    Mov Disord; 1994 Nov; 9(6):616-21. PubMed ID: 7845401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm.
    Wabbels B; Jost WH; Roggenkämper P
    J Neural Transm (Vienna); 2011 Jun; 118(6):925-43. PubMed ID: 21221669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic criteria for blepharospasm: A multicenter international study.
    Defazio G; Jinnah HA; Berardelli A; Perlmutter JS; Berkmen GK; Berman BD; Jankovic J; Bäumer T; Comella C; Cotton AC; Ercoli T; Ferrazzano G; Fox S; Kim HJ; Moukheiber ES; Richardson SP; Weissbach A; Wrigth LJ; Hallett M
    Parkinsonism Relat Disord; 2021 Oct; 91():109-114. PubMed ID: 34583301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.
    Goetz CG; Nutt JG; Stebbins GT
    Mov Disord; 2008 Dec; 23(16):2398-403. PubMed ID: 19025759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in patients with focal dystonia.
    Pekmezovic T; Svetel M; Ivanovic N; Dragasevic N; Petrovic I; Tepavcevic DK; Kostic VS
    Clin Neurol Neurosurg; 2009 Feb; 111(2):161-4. PubMed ID: 18995953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a clinical guideline for diagnosing blepharospasm.
    Defazio G; Hallett M; Jinnah HA; Berardelli A
    Neurology; 2013 Jul; 81(3):236-40. PubMed ID: 23771487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystonia rating scales: critique and recommendations.
    Albanese A; Sorbo FD; Comella C; Jinnah HA; Mink JW; Post B; Vidailhet M; Volkmann J; Warner TT; Leentjens AF; Martinez-Martin P; Stebbins GT; Goetz CG; Schrag A
    Mov Disord; 2013 Jun; 28(7):874-83. PubMed ID: 23893443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
    Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
    J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective, computerized video-based rating of blepharospasm severity.
    Peterson DA; Littlewort GC; Bartlett MS; Macerollo A; Perlmutter JS; Jinnah HA; Hallett M; Sejnowski TJ
    Neurology; 2016 Nov; 87(20):2146-2153. PubMed ID: 27770067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a muscular dystrophy-specific functional rating scale.
    Lue YJ; Su CY; Yang RC; Su WL; Lu YM; Lin RF; Chen SS
    Clin Rehabil; 2006 Sep; 20(9):804-17. PubMed ID: 17005504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale.
    Leentjens AF; Dujardin K; Pontone GM; Starkstein SE; Weintraub D; Martinez-Martin P
    Mov Disord; 2014 Jul; 29(8):1035-43. PubMed ID: 24862344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.